Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conscious sedation in emergency department using dexmedetomidine + alfentanil
2014-005170-11Phase 4Completed
- Sponsor
- Cliniques universitaires Saint-Luc
- Start
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of dexmedetomidine and alfentanil in procedural pain and anxiety disorder, sponsored by Cliniques universitaires Saint-Luc. Primary endpoint: Adequate level of conscious sedation with dexmedetomidine + alfentanil. Started Nov 2014; status: completed.
02
Drugs
dexmedetomidinealfentanil
03
Conditions
procedural painanxiety disorder
Beyond the preview
Go deeper on 2014-005170-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005170-11.